Ad is loading...
MENU
JANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Janux Therapeutics (JANX) Ownership - Who owns Janux Therapeutics?
Profile
Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
64
Web
https://www.januxrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.56B
P/E Ratio
N/A
Total Cash
646.29M
Projected Growth
N/A
Total Debt
23.82M
Revenue
15.13M
Risk (Beta)
3.52
Dividend Yield
N/A
Total Cash/Share
12.31
Total Debt/Equity
N/A
Revenue/Share
0.25 USD as % of share price
Fundamentals
JANX
Capitalization
2.56B
P/E Ratio
N/A
Risk (Beta)
3.52
Dividend Yield
N/A
Total Cash
646M
Total Cash/Share
12.31
Total Debt
23.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.25%
Revenue
15.1M
ROE
N/A
Book Value
658M
P/B Ratio
3.90
Cash Flow
N/A
Earnings
-0.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
52K
Current Ratio
57.34
Current Revenue Per Employee
128942.03
Dividends Per Share - Security
N/A
EBITDA
-63.86M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-8.53
Shares Held By Institutions
2.91B
Shares Outstanding - Current
52.5M
Total Liabilities
33.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
354.427
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
64
Web
https://www.januxrx.com